208 related articles for article (PubMed ID: 29551284)
1. Atractylodin attenuates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome and TLR4 pathways.
Tang F; Fan K; Wang K; Bian C
J Pharmacol Sci; 2018 Apr; 136(4):203-211. PubMed ID: 29551284
[TBL] [Abstract][Full Text] [Related]
2. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
4. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
5. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
6. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
8. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
9. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
Tian L; Li W; Wang T
Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
[TBL] [Abstract][Full Text] [Related]
11. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
12. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway.
Ma C; Zhu L; Wang J; He H; Chang X; Gao J; Shumin W; Yan T
J Ethnopharmacol; 2015 Jun; 168():349-55. PubMed ID: 25861954
[TBL] [Abstract][Full Text] [Related]
14. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice.
Zhou F; Zhang Y; Chen J; Hu X; Xu Y
Eur J Pharmacol; 2016 Nov; 791():735-740. PubMed ID: 27756605
[TBL] [Abstract][Full Text] [Related]
16. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
Liu X; Jin X; Yu D; Liu G
Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
[TBL] [Abstract][Full Text] [Related]
17. Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation.
Zhang B; Wang B; Cao S; Wang Y; Wu D
Int J Mol Med; 2017 May; 39(5):1111-1118. PubMed ID: 28350048
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
Tang Y; Chen Y; Chu Z; Yan B; Xu L
Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
20. Effects of alliin on LPS-induced acute lung injury by activating PPARγ.
Wang YL; Guo XY; He W; Chen RJ; Zhuang R
Microb Pathog; 2017 Sep; 110():375-379. PubMed ID: 28711511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]